Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

5.7K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sympathetic nervous system-mediated fibro-adipogenic progenitor mobilization drives stroke-related sarcopenia.

Cell discovery·2026
Same author

Soft substrate priming erases fibrotic mechanical memory in mesenchymal stromal cells via YAP lysosomal degradation to improve therapeutic efficacy for spinal cord injury.

Biomaterials·2026
Same author

Antimicrobial-potentiated colorectal cancer therapy with synchronized tumoricidal immunity via a self-deliverable nanopeptide.

Acta biomaterialia·2026
Same author

Restoring the FOXO1 geroprotective pathway via seno-resistant mesenchymal progenitor cells alleviates primate epididymal aging.

Protein & cell·2026
Same author

Technical Specification for Hemocompatibility Assessment of Human Mesenchymal Stem Cells.

Cell proliferation·2026
Same author

Role of claudin-6 in high-grade endometrial carcinoma: Implications for risk stratification and personalized treatment strategies.

World journal of clinical oncology·2026

Related Experiment Video

Updated: Mar 3, 2026

Retroviral Overexpression of CXCR4 on Murine B-1a Cells and Adoptive Transfer for Targeted B-1a Cell Migration to the Bone Marrow and IgM Production
08:22

Retroviral Overexpression of CXCR4 on Murine B-1a Cells and Adoptive Transfer for Targeted B-1a Cell Migration to the Bone Marrow and IgM Production

Published on: May 31, 2020

5.6K

CXCR5-Overexpressing Mesenchymal Stromal Cells Exhibit Enhanced Homing and Can Decrease Contact Hypersensitivity.

Xiaoran Zhang1, Weijun Huang2, Xiaoyong Chen1

  • 1Biotherapy Center, Third Affiliated Hospital, Sun Yat-Sen University, Guangzhou 510275, China; Center for Stem Cell Biology and Tissue Engineering, Key Laboratory for Stem Cells and Tissue Engineering, Ministry of Education, Sun Yat-Sen University, Guangzhou 510275, China.

Molecular Therapy : the Journal of the American Society of Gene Therapy
|April 30, 2017
PubMed
Summary

Genetically engineered mesenchymal stromal cells (MSCs) overexpressing CXCR5 show enhanced migration to injured tissues. This improved homing significantly boosts their therapeutic efficacy in treating inflammatory conditions like contact hypersensitivity.

Keywords:
CXCR5contact hypersensitivityhomingimmunomodulationmesenchymal stromal cells

More Related Videos

Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy
10:39

Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy

Published on: April 16, 2019

8.2K
Efficient Retroviral Transduction and Competitive Homing for Investigating GPCR-Mediated T-Cell Localization in Diverse Tissue Microenvironments
09:12

Efficient Retroviral Transduction and Competitive Homing for Investigating GPCR-Mediated T-Cell Localization in Diverse Tissue Microenvironments

Published on: March 28, 2025

707

Related Experiment Videos

Last Updated: Mar 3, 2026

Retroviral Overexpression of CXCR4 on Murine B-1a Cells and Adoptive Transfer for Targeted B-1a Cell Migration to the Bone Marrow and IgM Production
08:22

Retroviral Overexpression of CXCR4 on Murine B-1a Cells and Adoptive Transfer for Targeted B-1a Cell Migration to the Bone Marrow and IgM Production

Published on: May 31, 2020

5.6K
Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy
10:39

Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy

Published on: April 16, 2019

8.2K
Efficient Retroviral Transduction and Competitive Homing for Investigating GPCR-Mediated T-Cell Localization in Diverse Tissue Microenvironments
09:12

Efficient Retroviral Transduction and Competitive Homing for Investigating GPCR-Mediated T-Cell Localization in Diverse Tissue Microenvironments

Published on: March 28, 2025

707

Area of Science:

  • Immunology
  • Regenerative Medicine
  • Cell Therapy

Background:

  • Mesenchymal stromal cells (MSCs) show therapeutic potential for tissue regeneration and immunomodulation.
  • Enhancing MSC migration to injured sites is crucial for improving cell-based therapy efficacy.
  • CXCL13 is significantly upregulated in injured tissues, but MSCs lack its receptor, CXCR5.

Purpose of the Study:

  • To engineer MSCs overexpressing CXCR5 (MSCCXCR5) to enhance their migratory properties.
  • To evaluate the therapeutic efficacy of MSCCXCR5 in a mouse model of contact hypersensitivity (CHS).

Main Methods:

  • Generated MSCCXCR5, confirming retention of proliferation, differentiation, and immunomodulatory functions.
  • Assessed MSCCXCR5 migration towards CXCL13 in vitro.
  • Utilized a mouse model of CHS to evaluate the in vivo therapeutic effects of MSCCXCR5 infusion.

Main Results:

  • MSCCXCR5 exhibited significantly increased migration towards CXCL13.
  • Systemic infusion of MSCCXCR5 dramatically suppressed CHS, reducing inflammatory cell infiltration and pro-inflammatory cytokine production.
  • Administered MSCCXCR5 localized to inflamed tissues, inhibited T cell proliferation, promoted T cell apoptosis, and suppressed T cell-derived inflammatory factors.

Conclusions:

  • CXCR5 overexpression enhances MSCs' response to migratory cues, improving their homing to inflamed tissues.
  • Engineered MSCCXCR5 demonstrate intensified immunomodulatory effects in vivo.
  • Targeted enhancement of stem/progenitor cell homing via CXCR5 overexpression offers a promising strategy to improve MSC-based therapies.